Melzer, Y. F., Fergen, N. L., Mess, C., Stadler, J., Geidel, G., Schwietzer, Y. A., . . . Gebhardt, C. (2025). Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition. Translational Oncology, 52(102224-), . https://doi.org/10.1016/j.tranon.2024.102224
Chicago-referens (17:e uppl.)Melzer, Yasmin F., et al. "Evaluation of S100A8/A9 and Neutrophils as Prognostic Markers in Metastatic Melanoma Patients Under Immune-checkpoint Inhibition." Translational Oncology 52, no. 102224- (2025). https://doi.org/10.1016/j.tranon.2024.102224.
MLA-referens (9:e uppl.)Melzer, Yasmin F., et al. "Evaluation of S100A8/A9 and Neutrophils as Prognostic Markers in Metastatic Melanoma Patients Under Immune-checkpoint Inhibition." Translational Oncology, vol. 52, no. 102224-, 2025, https://doi.org/10.1016/j.tranon.2024.102224.
